Transfusion and Apheresis Science
Volume 42, Issue 2 , Pages 177-183 , April 2010

Human γ-herpesviruses: A review of 2 divergent paths to oncogenesis

  • Diana Ruth Hardie

      Affiliations

    • Corresponding Author InformationPresent address: C18 Laboratory, Groote Schuur Hospital, Anzio Road, Observatory, 7925 Cape Town, South Africa. Tel.: +27 29 4045201; fax: +27 21 4475683.

References 

  1. Cohen J. Epstein Barr virus infection. New Engl J Med. 2000;343:481–492
  2. Rezk SA, Lawrence M, Weiss MD. Epstein Barr virus-associated lympho-proliferative disorders. Hum Pathol. 2007;38:1293–1304
  3. Barozzi P, Potenza L, Riva G, et al. B cells and herpesviruses: a model of lympho-proliferation. Autoimmun Rev. 2007;7:132–136
  4. Snow AL, Martinez OM. Epstein Barr virus: evasive maneuvers in the development of PTLD. Am J Transplant. 2007;7:271–277
  5. Dolcetti R. B lymphocytes and Epstein Barr virus: the lesson of post transplant lympho-proliferative disorders. Autoimmun Rev. 2007;7:96–101
  6. Carbone A, Gloghini A, Dotti G. EBV-associated lympho-proliferative disorders: classification and treatment. Oncologist. 2008;13:577–585
  7. Kulwichit W, Edwards RH, Davenport EM, et al. Expression of the Epstein Barr latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci USA. 1998;95:11963–11968
  8. Orem J, Mbidde EK, Lambert B, et al. Burkitt’s lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci. 2007;7:166–175
  9. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet. 1964;1(7335):702–703
  10. Weiss LM, Movahed LA, Warnke RA, et al. Detection of Epstein Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. New Engl J Med. 1989;320:502–506
  11. Roth J, Daus H, Gause A, et al. Detection of Epstein Barr virus DNA in Hodgkin and Reed-Sternberg cells by single cell PCR. Leuk Lymphoma. 1994;13:137–142
  12. Gross TG, Loechelt BJ. Epstein Barr blood virus-associated disease following blood or marrow transplant. Pediatr Transplant. 2003;7(suppl 3):44–50
  13. Bakker NA, van Imhoff GW, Verschuuren EAM, et al. Presentation and early detection of post transplant lympho-proliferative disorder after solid organ transplantation. Transpl Int. 2006;20:207–218
  14. Pietersma F, Piriou E, van Baarle D. Immune surveillance of EBV-infected B cells and the development of non Hodgkin lymphomas in immunocompromised patients. Leuk Lymphoma. 2008;49:1028–1041
  15. Piriou E, van Dort K, Nanlohy NM, et al. Loss of EBNA 1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma. Blood. 2008;106:3166–3174
  16. Riddler SA, Breinig MC, McKnight JL. Increased levels of circulating Epstein Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of post transplant lympho-proliferative disease in solid organ transplant recipients. Blood. 1994;84:972–984
  17. Piriou E, van Dort K, Otto S, et al. Tight regulation of the Epstein Barr virus set point: inter individual differences in Epstein Barr virus DNA load are conserved after HIV infection. Clin Infect Dis. 2008;46:313–316
  18. Corcoran C, Rebe K, van der Plas H, et al. The predictive value of cerebrospinal fluid Epstein Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons. J Clin Virol. 2008;42:433–436
  19. Chang Y, Cesarman E, Pressin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS associated Kaposi’s sarcoma. Science. 1994;266:1865–1869
  20. Carbone A, Gloghini A. KSHV/HHV8-associated lymphomas. Br J Haematol. 2007;140:13–24
  21. Schwartz RA, Micali G, Nasca MR, et al. Kaposi’s sarcoma: a continuing conundrum. J Am Acad Derm. 2008;59:179–206
  22. Laurent C, Meggetto F, Brousset P. Human herpesvirus 8 infections in patients with immuno-deficiencies. Hum Pathol. 2008;39:983–993
  23. Rezaee SAR, Cunningham C, Davison AJ, et al. Kaposi’s sarcoma associated herpesvirus immune modulation: an overview. J Gen Virol. 2006;87:1781–1804
  24. Liang C, Lee J-S, Jung JU. Immune evasion in Kaposi’s sarcoma associated herpes virus associate oncogenesis. Semin Cancer Biol. 2008;18:423–436
  25. Grisotto MG, Garin A, Martin AP, et al. The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells. J Clin Invest. 2006;116:1264–1273
  26. Montaner S. Akt/TSC/mTOR activation by the KSHV G protein coupled receptor, emerging insights into the molecular oncogenesis and treatment of Kaposi’s sarcoma. Cell Cycle. 2007;6:438–443

PII: S1473-0502(10)00016-9

doi: 10.1016/j.transci.2010.01.015

Transfusion and Apheresis Science
Volume 42, Issue 2 , Pages 177-183 , April 2010

Article Tools